FTSE 100 today: Stocks climb, pound rises; ECB holds rates

The European Central Bank maintained its deposit rate at 2%, pausing its easing cycle as inflation nears target, a decision that aligned with market expectations and contributed to broad gains across European equities, including the FTSE 100. Individual company performance also drove market activity, with Trainline surging over 12% on a raised profit outlook and Energean posting strong first-half earnings. Significantly, Merck announced the abandonment of its £1 billion UK research hub, citing insufficient government investment and inadequate drug payment, posing a notable challenge to the UK's life sciences sector.

Analysis

European markets exhibited broad strength, evidenced by gains in the FTSE 100 (+0.8%), DAX (+0.3%), and CAC 40 (+0.8%), alongside a rise in the British pound to 1.3575 against the dollar. This positive sentiment was underpinned by the European Central Bank's decision to hold its deposit rate at 2.0%, a move that was widely anticipated and signals a pause in its monetary easing cycle as inflation stabilizes near its 2% target. On a corporate level, several UK-listed companies provided significant catalysts. Trainline PLC (LON:TRNT) shares surged over 12% after it raised its annual profit outlook on the back of an 8% rise in H1 net ticket sales. THG Holdings PLC (LON:THG) also gained over 6% after reaffirming its 2025 earnings guidance and pointing to stronger second-half momentum, despite a year-over-year drop in H1 EBITDA to £24 million. Energean Oil & Gas PLC (LON:ENOG) reported a mixed but well-received update; its stock rose on stronger-than-expected H1 earnings, with adjusted EBITDAX beating consensus by 13%, even as the company cut its 2025 production guidance. In contrast, a significant negative development emerged from Merck & Co. (NYSE:MRK), which abandoned its £1 billion UK research hub, citing insufficient government investment and unfavorable drug pricing, a considerable setback for the UK's life sciences sector. Concurrently, Ryanair's CEO highlighted drone activity as a persistent operational disruption for the airline industry.

Key Decisions for Investors

• Investors should consider the positive momentum in UK consumer-facing stocks like Trainline, whose raised guidance and strong sales data suggest robust domestic demand, but remain cautious about the broader UK investment climate following Merck's significant withdrawal.
• For Energean, the strong H1 earnings beat should be weighed against the lowered 2025 production guidance, indicating that while current profitability is high, long-term operational risks have increased and require careful monitoring.
• Merck's decision serves as a material warning for the UK life sciences sector; portfolios with heavy exposure to UK-based R&D or pharmaceutical firms should be re-evaluated for potential risks related to government policy and investment incentives.
• The commentary on drone disruptions from Ryanair's CEO flags a recurring operational headwind for the airline sector, suggesting investors should factor in potential margin pressure from increased flight disruptions and associated costs when valuing airline stocks.